male pattern baldness

(redirected from Male Pattern Hair Loss)
Also found in: Thesaurus, Medical, Acronyms.

male pattern baldness

n.
Progressive loss of scalp hair in men that usually begins in early adulthood and characteristically leads to loss of hair on the crown and above the temples; androgenetic alopecia. Also called male pattern hair loss.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.male pattern baldness - loss of hair on the crown of the headmale pattern baldness - loss of hair on the crown of the head
baldness, phalacrosis - the condition of having no hair on the top of the head
References in periodicals archive ?
Finasteride (Propecia) is a prescription medication that is FDA approved to treat male pattern hair loss.
A control group of 29 men who had male pattern hair loss but had never taken finasteride nor had any history of psychiatric problems were also interviewed.
A man whose father has even a minimal amount of hair loss who tests positive for the variant AR gene has over 80% chance of developing male pattern hair loss," says Andy Goren, President and CEO of HairDX.
Acquisition Adds Setipiprant (KYTH-105), Novel Compound and Potential Treatment for Male Pattern Hair Loss --
The study looked at the reported types and duration of persistent sexual side effects in otherwise healthy men who took finasteride for male pattern hair loss," said Dr.
The study's lead author Dr Angela Christiano, professor of dermatology and genet ics and development at the university's medical centre, said: "The identification of this gene has afforded us an opportunity to gain insight into the process of hair follicle miniaturisation, most commonly observed in male pattern hair loss or androgenetic alopecia.
Through theses means, Banyu aims to raise awareness of AGA, male pattern hair loss.
He lectures around the world and has appeared as an expert on female and male pattern hair loss and their current treatments, including hair transplant surgery, medical intervention, laser therapy, and ethics.
In May 2015, Histogen opened its Series D financing round to support clinical development of its Hair Stimulating Complex (HSC), including a US Phase I clinical trial in female diffuse hair loss patients and a late-stage HSC trial in male pattern hair loss, expand its manufacturing capability, and to support preparation for an initial public offering (IPO).